TrademarkDir
ULTRATRACE
DEAD

Serial Number

78698536

Owner

Molecular Insight Pharmaceuticals, Inc.

Attorney

Phi Lan Tinsley

First Use Date

Apr 24, 2006

Filing Date

Aug 23, 2005

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ULTRATRACE Trademark

Serial Number: 78698536 • Registration: 3613887

ULTRATRACE is a trademark filed by Molecular Insight Pharmaceuticals, Inc. on August 23, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Molecular Insight Pharmaceuticals, Inc. (25 trademarks)

160 Second Street
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

August 23, 2005

Registration Date

April 28, 2009

First Use Anywhere

April 24, 2006

First Use in Commerce

April 24, 2006

Published for Opposition

April 3, 2007

Cancellation Date

October 21, 2020

Goods & Services

Radiopharmaceutical preparations for targeted radiotherapy of cancer

Filing History

NOTICE OF CANCELLATION SEC. 8 EMAILED
Oct 22, 2020 NCS8
CANCELLED SEC. 8 (10-YR)
Oct 21, 2020 C8.T
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 21, 2020 APRE
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 16, 2020 ASCK
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Dec 23, 2019 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 7, 2019 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 23, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 28, 2018 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 5, 2017 ASCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 1, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 1, 2017 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 6, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 6, 2015 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 4, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 22, 2015 E815
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 23, 2013 ASCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 29, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 29, 2012 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 1, 2011 ASCK
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2009 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Mar 23, 2009 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 21, 2009 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2009 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 9, 2009 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 29, 2008 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 29, 2008 AITU
USE AMENDMENT FILED
Dec 12, 2008 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 12, 2008 EISU
SOU EXTENSION 2 GRANTED
May 27, 2008 EX2G
SOU EXTENSION 2 FILED
May 27, 2008 EXT2
SOU TEAS EXTENSION RECEIVED
May 27, 2008 EEXT
SOU EXTENSION 1 GRANTED
Apr 3, 2008 EX1G
SOU EXTENSION RECEIVED WITH TEAS PETITION
Mar 21, 2008 TPEX
PETITION TO REVIVE-GRANTED
Mar 21, 2008 PETG
TEAS PETITION TO REVIVE RECEIVED
Mar 21, 2008 PROA
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 5, 2008 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 5, 2008 ABN6
SOU EXTENSION 1 FILED
Dec 26, 2007 EXT1
ASSIGNED TO EXAMINER
Oct 11, 2007 DOCK
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 26, 2007 NOAM
PUBLISHED FOR OPPOSITION
Apr 3, 2007 PUBO
NOTICE OF PUBLICATION
Mar 14, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 20, 2007 PREV
ASSIGNED TO LIE
Feb 20, 2007 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 15, 2007 CNSA
AMENDMENT FROM APPLICANT ENTERED
Oct 16, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 10, 2006 TROA
NON-FINAL ACTION E-MAILED
Mar 11, 2006 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2006 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2006 DOCK
NEW APPLICATION ENTERED
Aug 31, 2005 NWAP

Related Trademarks

More from this Owner

AZEDRA

AZEDRA

AZEDRA

AZEDRA

AZEDRA

AZEDRA

MOLECULARINSIGHT PHARMACEUTICALS logo

MOLECULARINSIGHT PHARMACEUTICALS

MOLECULARINSIGHT PHARMACEUTICALS logo

MOLECULARINSIGHT PHARMACEUTICALS

ZEMIVA

ZEMIVA